راهبردهای سیاستی برای نوآوری در توسعه و تولید واکسن با نگاهی به چالش‎های جاری

مراجع و منابع این مقاله:

• ستاد توسعه زیست‎فناوری کشور (اردیبهشت 1394) برنامه عملیاتی کارگروه واکسن، ...
• سرلک، محمدعلی؛ ویسه، سیدمهدی؛ پوراشرف، یاسان ا... و مهدی‎زاده، حسین ...
• کریمی، صدیقه؛ نصر، احمدرضا (1392)، روش های تجزیه وتحلیل داده‎های ...
• قدسی، محمد (1350) تاریخچه خدمات 50 ساله انستیتو پاستور ایران، ...
• شناسایی مزیت های نسبی و فرصت های سرمایه گذاری در کشور، شالوده رویکرد موثر به تحقیق و توسعه [مقاله کنفرانسی]
• مرندی، وحید (1380) توسعه صنعتی زیست‎فناوری در کشور، اهمیت و ...
• مرندی، وحید (1383) مورد کاوی تحقق اهداف و تحلیل رویکردهای ... [مقاله کنفرانسی]
• تحلیل مولفه مدیریت دانایی در یک پروژه راهبردی ملی [مقاله کنفرانسی]
• ABPI. Written evidence to House of Commons Science and Technology ...
• Amit, R. and Zott, C. (2001) ‘Value creation in e-business’, ...
• Bernstein, B. Singh.P.J. (2006) an integrated innovation process model based ...
• Big pharma has higher profit margins than any other industry, ...
• Chaturvedi, K. and Chataway, J.  (2012) Strategic integration of knowledge ...
• Clemens. J.D. Jodar.L (2004)  Translational research to assist policy decisions ...
• Folkers.G.K, Fauci.A.S, (2003) Vaccine Research and Development: The Key Roles ...
• Garnier, J.P (2008), Rebuilding the R&D machine in big pharma, ...
• Haeussler, C. (2007) Proactive versus reactive m&a activities in the ...
• Hardman Reis.T (2006) the role of intellectual property in the ...
• How brexit would impact pharma, (cited 2016June7), Available from: URL: ...
• Innovation in Pharmaceutical Biotechnology: Comparing national innovation systems at the ...
• International Monetary Fund Report (2014) IMF Survey: More efficient public ...
• KFDA (2012) recent trends and Korea’s cases in the development ...
• http://www.bioin.or.kr/upload.do cmd=download&seq=7676&bid=industry.Accessedon 4/5/2012. ...
• Keen, P. Qureshi, S. (2006) Organizational transformation through business models: ...
• Kellogg, J.L. (2002) Managing R&D in the biotechnology Sector, Kellogg ...
• Kurdin.A (2012) Business models and opportunities for cancer vaccine developers, ...
• Kleinbaum, A. Tushman, M (2007) Building bridges: the social structure ...
• Malone.K.M, Hinman.A.R, (2007) Vaccination mandates: The public health imperative & ...
• Market entry of 9 new recombinant pharmaceuticals, (cited 2015 May ...
• Matherne, B.P. (2007) Does whom you know matter in venture ...
• McDonough, III, E.F. Athanassiou, N. Barczak, G. (2006) Networking for ...
• McGrath, R. Nerkar, A. (2004) Real options reasoning and a ...
• Nerkar, A.Roberts, P. (2004) Technological and product-market experience and the ...
• Newall, A.T. Reyes, J.F. Wood, J.G. McIntyre, P. Menzies, R. ...
• Olesen.O.F, Lonnroth.A, Mulligan.B, (2009) Human vaccine research in the European ...
• Oyston.P, Robinson.K, The current challenges for vaccine development (2012) Journal ...
• Qian, G, Wang, D (2000) Factors that affect performance of ...
• Qian, G, Li, L. (2003) Profitability of small- and medium-sized ...
• Rathore. A. S, Bhalghat. M, Patra. A.K (2012) Key Considerations ...
• Report in support of knowledge based companies, (cited 2017March28), Available ...
• Rhyne.L.C (2009) Business model design for biotechnology firms, International Journal ...
• Rice, M. O’Conner, S. and Pierantozyi, R. (2008) Implementing a ...
• Rothaermel, F, Deeds, D. (2004) Exploration and exploitation alliances in ...
• Rottingen.J.A, Regmi.S, Eide.M, (2013) Mapping of available health research and ...
• Seelos, C, Mair, J (2007) Profitable business models and market ...
• Stam, W. Elfring, T (2008) Entrepreneurial orientation and new venture ...
• Teece, D (1982)  Toward an economic theory of the multiproduct ...
• Thomas, L (2004) Are we all global now Local vs. ...
• Thompson, K. M. Tebbens, R. J. Pallansch, M. A. Kew, ...
• Tolstoy, D. Agndal, H. (2008) Network resource combinations in new ...
• Voss, G. Sirdeshmukh, D. Voss, Z. (2008) The effects of ...
• Wasserman.E, (2016) Astellas cancer med Xtandi draws fire as U.S. ...
• Wells, R.M.J. (2008) the product innovation process: are managing information ...
• Widdus. R. (2010) Vaccine Innovation done differently, Bulletin of the ...
• Woiceshyn, J. Folkenberg, L (2008) Value creation in knowledge-based firms: ...
• World Bank. (2006) Korea as a Knowledge Economy:Evolutionary Process and ...
• World Bank. (2017) Doing Business: 2018, the World Bank, Oct. ...
• Zhao, R. (2003) Transition in R&D management control system: case ...
نمایش کامل مراجع